Skip to main content
NIH funding notice PAR-20-122

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

Closed on September 7, 2023.

Posted
March 3, 2020
Close date
September 7, 2023
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,146,737 in first-year total cost, median $661,980.

Most frequent study sections

  1. Special Emphasis Panel[ZNS1 SRB-Q (04)]2
  2. Special Emphasis Panel[ZNS1 SRB-T (50)]2
  3. Special Emphasis Panel[ZNS1 SRB-T (48)]1

Most frequent institutions

  1. EMORY UNIVERSITY1
  2. MASSACHUSETTS GENERAL HOSPITAL1
  3. STANFORD UNIVERSITY1
  4. UNIVERSITY OF FLORIDA1
  5. UNIVERSITY OF MIAMI SCHOOL OF MEDICINE1
Competing awards under PAR-20-122 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2023Cyclic Peptides to Treat Cocaine Use Disorder1UG3NS132600-01ALDRICH, JANE VBIDLACK, JEAN MMCLAUGHLIN, JAY P.UNIVERSITY OF FLORIDA, FL$945,491ZNS1
2023Development of a splicing modulator compound for familial dysautonomia1UG3NS132462-01SLAUGENHAUPT, SUSAN AMASSACHUSETTS GENERAL HOSPITAL, MA$211,439ZNS1
2022Optimization of EP2 Antagonists for Post-Seizure Cognitive Deficits1UG3NS127386-01DINGLEDINE, RAYMOND JGANESH, THOTAEMORY UNIVERSITY, GA$677,532ZNS1
2022Development of selective cannabinoid receptor 2 agonists for treatment of addiction1UG3NS127382-01SHAMLOO, MEHRDADSTANFORD UNIVERSITY, CA$661,980ZNS1
2022Developing a kinase inhibitor drug to treat spinal cord injury1UG3NS124630-01AL-ALI, HASSANBIXBY, JOHN LLEMMON, VANCE PUNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL$650,295ZNS1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-20-122: Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) | ScienceDex | ConductScience